[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:proliferative-verrucous-leukoplakia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Proliferative Verrucous Leukoplakia",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03603223","Pembrolizumab in Treating Participants With Leukoplakia",[11],"Phase 2","RECRUITING","2026-08-26T02:19:08.084946Z","2026-05-05T02:43:27.632404Z",[],[]]